Historical record - last NADAC effective date: 8/18/2021
Product Information
METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.3816 per EA under NDC 68001036003. Its NADAC has been published 135 times since Feb 6, 2019.
FDA first approved this application on Feb 6, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Metoprolol Succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001036003
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204106FDA Approved
2/6/2018
TE Code
AB
On Market Since
6/29/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 135 times since Feb 6, 2019, and over the history we have for it it has declined 22.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3816 per EA |
|---|---|
| All-time high | $0.5573 (Aug 14, 2019) |
| All-time low | $0.3478 (Oct 21, 2020) |
| Median price | $0.4109 |
| Average price | $0.4320 |
| Largest weekly change | +26.0% (Jan 20, 2021) |
| Weeks tracked | 135 |
| Tracking since | Feb 6, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-22.2%
Last surveyed Sep 1, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol Succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by BluePoint Laboratories, is $0.3816 per EA (NDC 68001036003), effective Sep 1, 2021.
How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 22.2%. It has been tracked across 135 weekly CMS publications since Feb 6, 2019.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?
Since Feb 6, 2019, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.3478 (Oct 21, 2020) to a high of $0.5573 (Aug 14, 2019), with a median of $0.4109 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1678 per EA — about 56% below METOPROLOL SUCC ER 200 MG TAB.
Who manufactures METOPROLOL SUCC ER 200 MG TAB?
METOPROLOL SUCC ER 200 MG TAB (NDC 68001036003) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.